In vitro differentiation of bone marrow derived porcine mesenchymal stem cells to endothelial cells

Mesenchymal stem cells (MSCs) hold potential for the regeneration of damaged tissues in cardiovascular diseases. In this study, we investigated the potential of porcine MSCs to differentiate into endothelial cells (ECs) in vitro. The cultured bone marrow‐derived cells were CD11b–CD34–CD44+CD45–CD90+ and showed mesodermal lineage differentiation, which is characteristic of MSCs. The MSCs were induced to differentiate into ECs using endothelial growth medium (EGM), with and without high concentrations of VEGF (EGM + VEGF; 50 ng/ml). Endothelial basal medium (EBM) without growth factors served as the control. The EC differentiation was assessed by the presence of vWF, ability to take up acetylated LDL, in vitro angiogenesis assay, flow cytometry and qPCR of EC markers vWF, VE‐cadherin, PECAM‐1, VEGF‐R1 and VEGF‐R2 after 10 days of stimulation. Cells cultured in EGM + VEGF medium demonstrated higher amounts of DiI‐AcLDL‐positive cells and enhanced the presence of vWF (90%), VE‐Cadherin‐ (60%) and PECAM‐1 (48%)‐positive cells, than in EBM. These cells showed profuse sprouting of capillary tubes and closed polygon formation in the angiogenesis assay. There was 1.5–2‐fold increase in the mRNA expression of endothelial markers in the cells stimulated with EGM + VEGF medium when compared to control. The results demonstrate the ability of porcine MSCs to differentiate into ECs under in vitro inducing conditions. The differentiated cells would provide new options for re‐endothelialization following interventional procedures and tissue engineering. Copyright © 2012 John Wiley & Sons, Ltd.

[1]  F. Djouad,et al.  Immunosuppression by mesenchymal stem cells: mechanisms and clinical applications , 2010, Stem Cell Research & Therapy.

[2]  B. Ratner,et al.  VEGF Induces Differentiation of Functional Endothelium From Human Embryonic Stem Cells: Implications for Tissue Engineering , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[3]  B. Black,et al.  Transcriptional control of endothelial cell development. , 2009, Developmental Cell.

[4]  R. Roskoski.  VEGF receptor protein-tyrosine kinases: structure and regulation. , 2008, Biochemical and biophysical research communications.

[5]  O. Lee,et al.  Stem cell therapy for liver disease: parameters governing the success of using bone marrow mesenchymal stem cells. , 2008, Gastroenterology.

[6]  Xiaoping Liu,et al.  MAPK/ERK signalling mediates VEGF-induced bone marrow stem cell differentiation into endothelial cell , 2008, Journal of cellular and molecular medicine.

[7]  Gerhard Ehninger,et al.  Mesenchymal Stem Cells Can Be Differentiated Into Endothelial Cells In Vitro , 2004, Stem cells.

[8]  B. Larson,et al.  Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential. , 2004, Blood.

[9]  O. Lee,et al.  Isolation of multipotent mesenchymal stem cells from umbilical cord blood. , 2004, Blood.

[10]  D. Kaufman,et al.  Functional endothelial cells derived from rhesus monkey embryonic stem cells. , 2004, Blood.

[11]  Shulamit Levenberg,et al.  Endothelial cells derived from human embryonic stem cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[12]  C. Verfaillie,et al.  Origin of endothelial progenitors in human postnatal bone marrow. , 2002, The Journal of clinical investigation.

[13]  H. Lorenz,et al.  Multilineage cells from human adipose tissue: implications for cell-based therapies. , 2001, Tissue engineering.

[14]  Jun Yamashita,et al.  Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors , 2000, Nature.

[15]  M. Pittenger,et al.  Multilineage potential of adult human mesenchymal stem cells. , 1999, Science.

[16]  D. Prockop.  Marrow Stromal Cells as Stem Cells for Nonhematopoietic Tissues , 1997, Science.

[17]  Takayuki Asahara,et al.  Isolation of Putative Progenitor Endothelial Cells for Angiogenesis , 1997, Science.

[18]  Kenneth J. Hillan,et al.  Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene , 1996, Nature.

[19]  J. Rossant,et al.  Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium , 1995, Nature.

[20]  M. Lampugnani,et al.  A novel endothelial-specific membrane protein is a marker of cell-cell contacts , 1992, The Journal of cell biology.

[21]  B. Zetter,et al.  Identification and isolation of endothelial cells based on their increased uptake of acetylated-low density lipoprotein , 1984, The Journal of cell biology.

[22]  Catherine M. Verfaillie,et al.  Pluripotency of mesenchymal stem cells derived from adult marrow , 2007, Nature.

[23]  D. Prockop,et al.  Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. , 2006, Cytotherapy.

[24]  R. Nerem,et al.  Purified and proliferating endothelial cells derived and expanded in vitro from embryonic stem cells. , 2003, Endothelium : journal of endothelial cell research.

[25]  S. Rafii,et al.  VEGFR-3 and CD133 identify a population of CD34+ lymphatic/vascular endothelial precursor cells. , 2003, Blood.

[26]  Paul D. Kessler,et al.  Human Mesenchymal Stem Cells Differentiate to a Cardiomyocyte Phenotype in the Adult Murine Heart , 2002, Circulation.

[27]  A. Federici,et al.  Antibodies to von Willebrand factor in von Willebrand disease. , 1995, Advances in experimental medicine and biology.